Experts Discover A New Drug Compound That Treats Major Kidney Disease

Photo of author

(Newswire.net — March 18, 2020) Orlando, FL — The prevalence of chronic kidney disease (CKD) continues to soar, especially in the United States. In the country, it has been found to affect an estimated number of 37 million individuals. It is worth mentioning this equates to 15 percent of the adult population. 

Statistics further reveal that 1 in 3 adults in the U.S. or approximately 80 million people are at the risk of CKD. It is even considered to be the 9th top cause of death in the country. It is also worth mentioning that in 2016, more than 500,000 patients received dialysis treatment. 

Experts warn that CKD is an under-recognized public health crisis. It is also more common in women than in men.

The prevalence of kidney diseases continues to alarm more and more experts. This is why there are various studies exploring different aspects of kidney health, and this includes medications for the condition.

Scientists from the University of Sheffield are part of an international collaboration carried out a study.

This research aimed at developing a new class of drugs to treat a common genetic kidney disease, which is a major cause of kidney failure.

Mironid and colleagues in the US worked with the Glasgow-based biotech company. They tested a compound in the laboratory to treat autosomal dominant polycystic kidney disease (ADPKD).

It is worth mentioning that ADPKD is a hereditary, progressive disease that affects over 60,000 people in the UK and about 12 million people on a global scale.

The findings are published today (18 June 2019) in the US journal Proceedings of the National Academy of Sciences (PNAS).

Today, there are many studies looking into the best possible ways to protect and enhance kidney health.

One is ensuring that the body has adequate levels of essential vitamins and minerals. These include B vitamins, which could work in various ways to protect the kidneys. 

It is worth noting that in individuals with healthy kidneys and who consume various healthy foods, getting these nutrients is at all a problem. However, for those with chronic kidney disease who are on dialysis, their diet may limit some foods groups. 

B Vitamins like B6, B12, and folic acid could work together to help protect the kidneys.

These nutrients are also found to produce a range of healing benefits. This is why today, their increased intake is strongly recommended by researchers.

In experiencing their benefits, it may be wise to consider the use of formulas like Divine Bounty Vitamin B Complex.

It contains Choline, Pantothenic acid, Biotin, Vitamin B12, Folic Acid, Niacin, Riboflavin, Thiamin, and vitamin B6 (https://amazon.com/dp/B07414752B).

About Divine Bounty

Divine Bounty is a family-owned brand that manufactures high-quality turmeric curcumin supplements. Passionate about the potential health benefits of turmeric, the team behind Divine Bounty have carefully researched and sourced only the best ingredients to create the ideal blend of turmeric curcumin. More details are available at http://www.DivineBounty.com.

Divine Bounty

12001 Research Parkway
Suite 236 A
Orlando, FL 32826
United States
(407) 545 7738
media@divinebounty.com
http://www.DivineBounty.com